Aripiprazole for the treatment of methamphetamine dependence: a randomized, double‐blind, placebo‐controlled trial
Aims To test aripiprazole for efficacy in decreasing use in methamphetamine‐dependent
adults, compared to placebo. Design Participants were randomized to receive 12 weeks of
aripiprazole or placebo, with a 3‐month follow‐up and a platform of weekly 30‐minute
substance abuse counseling. Setting The trial was conducted from J anuary 2009 to M arch
2012 at the San Francisco Department of Public Health. Participants Ninety actively using,
methamphetamine‐dependent, sexually active adults were recruited from community …
adults, compared to placebo. Design Participants were randomized to receive 12 weeks of
aripiprazole or placebo, with a 3‐month follow‐up and a platform of weekly 30‐minute
substance abuse counseling. Setting The trial was conducted from J anuary 2009 to M arch
2012 at the San Francisco Department of Public Health. Participants Ninety actively using,
methamphetamine‐dependent, sexually active adults were recruited from community …
[引用][C] Aripiprazole for the treatment of methamphetamine dependence: A randomized, double-blind, placebo-controlled trial
Aripiprazole for the treatment of methamphetamine dependence: A randomized, double-blind,
placebo-controlled trial … Aripiprazole for the treatment of methamphetamine dependence:
A randomized, double-blind, placebo-controlled trial … Drug and Alcohol Dependence >
2014 > 140 > Complete > e36 …
placebo-controlled trial … Aripiprazole for the treatment of methamphetamine dependence:
A randomized, double-blind, placebo-controlled trial … Drug and Alcohol Dependence >
2014 > 140 > Complete > e36 …
以上显示的是最相近的搜索结果。 查看全部搜索结果